Skip to main content

Table 3 Univariate analysis of pre and post initial TACE serum AFP levels and association with overall survival

From: Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Variable n % Hazard Ratio Lower 95% CI Higher 95% CI P value
Baseline AFP ≥ 200 ng/ml 260 23% 1.48 1.07 2.04 0.015
Post initial TACE AFP ≥ 200 ng/ml 177 17% 2.19 1.43 3.36 <0.001
Baseline AFP ≥ 400 ng/ml 260 17% 1.36 0.95 1.95 0.088
Post Initial TACE AFP ≥ 400 ng/ml 177 13% 2.41 1.49 3.90 <0.001